Search - tctmd.com

Displaying 101 - 120 of 389

Sort: Relevancy | Date

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

News Industry News

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

October 26, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Industry News

Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation

October 21, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Industry News

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

October 13, 2015

News Industry News

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

October 13, 2015

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Silk Road Medical Announces First U.S. Commercial Case with the ENROUTE® Transcarotid Stent System

October 07, 2015

News Industry News

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

October 01, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

Advertisement

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Thrombus Aspiration During PCI Shows No Benefit To Standard PCI In Stemi Patients Presenting Late After Symptom Onset

Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

Scripps experts present at 2015 TCT scientific symposium

Boston Scientific Announces Scheduled Presentations At TCT 2015

Silk Road Medical Announces First U.S. Commercial Case with the ENROUTE® Transcarotid Stent System

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Ventrix Initiates Clinical Trial of VentriGel™

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content